Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Enhancement of physicochemical properties of nanocolloidal carrier loaded with cyclosporine for topical treatment of psoriasis: in vitro diffusion and in vivo hydrating action.

Musa SH, Basri M, Fard Masoumi HR, Shamsudin N, Salim N.

Int J Nanomedicine. 2017 Mar 28;12:2427-2441. doi: 10.2147/IJN.S125302. eCollection 2017.

2.

East Indian Sandalwood Oil (EISO) Alleviates Inflammatory and Proliferative Pathologies of Psoriasis.

Sharma M, Levenson C, Clements I, Castella P, Gebauer K, Cox ME.

Front Pharmacol. 2017 Mar 16;8:125. doi: 10.3389/fphar.2017.00125. eCollection 2017.

3.
4.

Chlorogenic acid prevents isoproterenol-induced DNA damage in vascular smooth muscle cells.

Wang J, Li J, Liu J, Xu M, Tong X, Wang J.

Mol Med Rep. 2016 Nov;14(5):4063-4068. doi: 10.3892/mmr.2016.5743. Epub 2016 Sep 15.

5.

Ulcerations due to methotrexate toxicity in a psoriasis patient.

Souza CF, Suarez OM, Silva TF, Gorenstein AC, Quintella LP, Avelleira JC.

An Bras Dermatol. 2016 May-Jun;91(3):375-7. doi: 10.1590/abd1806-4841.20163960.

7.

Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.

Koo J, Tyring S, Werschler WP, Bruce S, Olesen M, Villumsen J, Bagel J.

J Dermatolog Treat. 2016;27(2):120-7. doi: 10.3109/09546634.2015.1083935. Epub 2015 Oct 7.

8.

Loss of urokinase receptor sensitizes cells to DNA damage and delays DNA repair.

Narayanaswamy PB, Hodjat M, Haller H, Dumler I, Kiyan Y.

PLoS One. 2014 Jul 2;9(7):e101529. doi: 10.1371/journal.pone.0101529. eCollection 2014.

9.

Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.

Gooderham M, Debarre JM, Keddy-Grant J, Xu Z, Kurvits M, Goodfield M.

Br J Dermatol. 2014 Dec;171(6):1470-7. doi: 10.1111/bjd.13235. Epub 2014 Oct 22.

10.

Mechanisms of action of topical corticosteroids in psoriasis.

Uva L, Miguel D, Pinheiro C, Antunes J, Cruz D, Ferreira J, Filipe P.

Int J Endocrinol. 2012;2012:561018. doi: 10.1155/2012/561018. Epub 2012 Nov 5.

11.

Cassia tora Linn Cream Inhibits Ultraviolet-B-Induced Psoriasis in Rats.

Singhal M, Kansara N.

ISRN Dermatol. 2012;2012:346510. doi: 10.5402/2012/346510. Epub 2012 Mar 25.

12.

A Case of Cutaneous Side Effect of Methotrexate Mimicking Behçet's Disease.

Lee HJ, Hong SK, Seo JK, Lee D, Sung HS.

Ann Dermatol. 2011 Aug;23(3):412-4. doi: 10.5021/ad.2011.23.3.412. Epub 2011 Aug 18.

13.

Microparticulate based topical delivery system of clobetasol propionate.

Badıllı U, Sen T, Tarımcı N.

AAPS PharmSciTech. 2011 Sep;12(3):949-57. doi: 10.1208/s12249-011-9661-7. Epub 2011 Jul 12.

14.

The DNA-damage response in human biology and disease.

Jackson SP, Bartek J.

Nature. 2009 Oct 22;461(7267):1071-8. doi: 10.1038/nature08467. Review.

15.

A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.

Luger TA, Cambazard F, Larsen FG, Bourcier M, Gupta G, Clonier F, Kidson P, Shear NH.

Dermatology. 2008;217(4):321-8. doi: 10.1159/000155642. Epub 2008 Sep 12.

16.

Infliximab (Remicade) in the treatment of psoriatic arthritis.

Mease P.

Ther Clin Risk Manag. 2006 Dec;2(4):389-400.

17.

What is a role of haeme oxygenase-1 in psoriasis? Current concepts of pathogenesis.

Wojas-Pelc A, Marcinkiewicz J.

Int J Exp Pathol. 2007 Apr;88(2):95-102. Review.

18.

Psoriasis treatment: current and emerging directed therapies.

Winterfield LS, Menter A, Gordon K, Gottlieb A.

Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii87-90; discussion ii91-2. Review.

Supplemental Content

Support Center